Bevacizumab In Hereditary Hemorrhagic Telangiectasia
Clinical trial NCT04404881 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04404881
- Sponsor
- Hanny Al-Samkari, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2026-03-02
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.